Factor Therapeutics is an Australian biotechnology company pursuing the development and commercialisation of advanced wound care therapeutics. The Company’s lead programme, VF001, is a targeted growth factor that is being developed to treat venous leg ulcers (VLUs). Chronic wounds, such as VLUs, are common, painful and debilitating – a silent epidemic. Factor Therapeutics is a public company traded on the Australian Securities Exchange (ASX:FTT).
Looking for a particular Factor Therapeutics Ltd employee's phone or email?
The Factor Therapeutics Ltd annual revenue was $5.1 million in 2026.
Factor Therapeutics Ltd is based in Darra, Queensland.
The NAICS codes for Factor Therapeutics Ltd are [32, 32541, 325, 3254].
The SIC codes for Factor Therapeutics Ltd are [28, 283].